MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Continente #
EU - Europa 38246
Totale 38246
Nazione #
IT - Italia 38246
Totale 38246
Città #
Genova 35558
Rapallo 2054
Genoa 634
Totale 38246
Nome #
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 176
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 171
null 153
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 148
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 147
An updated Italian normative dataset for the Stroop color word test (SCWT) 143
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 143
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 140
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 139
Basal ganglia are active during motor performance recovery after a demanding motor task. 139
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 139
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 138
null 138
null 137
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 136
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 135
Neural correlates of ankle movements during different motor tasks: A feasibility study 134
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 133
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 131
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. 130
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 129
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 128
Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method. 128
Stem cells for multiple sclerosis: promises and reality. 127
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 126
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 126
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 126
null 126
Three years of experience: the Italian registry and safety data update 126
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 126
Anxiety and depression in multiple sclerosis patients around diagnosis. 125
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 125
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 124
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 124
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 124
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 124
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 124
Neurological research in Italy in 2003 and 2004. 123
null 123
Dysimmune mononeuropathies: A diagnosis not to be missed 123
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 122
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 122
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 122
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 122
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 121
null 121
Direct immunofluorescence in sural nerve biopsies. 121
Clinical epidemiology of ALS in Liguria, Italy. 121
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 121
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 121
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. 120
LOSS OF EPIDERMAL GROWTH FACTOR REGULATION BY COBALAMIN IN MULTIPLE SCLEROSIS 119
null 119
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. 119
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 119
null 118
A normative study of the Italian printed word version of the free and cued selective reminding test 118
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 118
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 118
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 118
The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. 118
The prevalence of multiple sclerosis in the north-west Italian province of Genoa. 117
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 117
Clinical features of Sjogren's syndrome in patients with multiple sclerosis. 117
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 116
HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE SCLEROSIS: COLLABORATION OF THE CIBMTR AND EBMT TO FACILITATE INTERNATIONAL CLINICAL STUDIES 116
null 116
null 115
Human mesenchymal stem cells promote survival of T cells in a quiescent state. 115
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. 114
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. 114
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 113
T137A variant is a pathogenetic SOD1 mutation associated with a slowly progressive ALS phenotype. 113
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 113
null 112
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. 112
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 112
Early degeneration of the cerebellar cortex, particularly the granular cells. 112
Skin fibroblasts in Huntington's disease. 112
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 112
Brain stroke imaging by means of microwave tomography: Quantitative inversion procedure, configuration set up, and preliminary experimental results 112
null 112
Autologous hemopoietic stem cell transplantation for multiple sclerosis: Is it worthwile? 111
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 111
Cranial MRI in ataxia-telangiectasia. 111
null 110
B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy. 110
GFAP expression of human Schwann cells in tissue culture. 110
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 110
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. 110
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 110
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 110
Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients. 110
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 109
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 109
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 108
A prospective study of acute idiopathic neuropathy II antecedent events. 108
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 108
null 108
Lowering body temperature with a cooling suit as symptomatic treatment for thermosensitive multiple sclerosis patients. 107
Totale 12237
Categoria #
all - tutte 55446
article - articoli 51248
book - libri 195
conference - conferenze 3672
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 331
Totale 110892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183658 0000 02010 573579 95041720
2018/20193598 945469 55309 6220 1361113151104
2019/202013301 559452585920 12241386 2171933 123920461246540
2020/20213527 275332396373 179256 196349 292385233261
2021/20225503 166399657696 170293 2871252 217496152718
2022/20232683 54443462522 879242 00 0000
Totale 38777